These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 12526724)
21. Estimation of effects of community intervention with antibiotics, facial cleanliness, and environmental improvement (A,F,E) in five districts of Ethiopia hyperendemic for trachoma. Ngondi J; Gebre T; Shargie EB; Adamu L; Teferi T; Zerihun M; Ayele B; King JD; Cromwell EA; Emerson PM Br J Ophthalmol; 2010 Mar; 94(3):278-81. PubMed ID: 19897474 [TBL] [Abstract][Full Text] [Related]
22. Azithromycin treatment levels inadequate for recommended trachoma control guidelines. Kelaher M; Ferdinand AS; Taylor HR Med J Aust; 2011 Jan; 194(2):102. PubMed ID: 21241228 [No Abstract] [Full Text] [Related]
23. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village. West SK; Munoz B; Mkocha H; Gaydos C; Quinn T Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476 [TBL] [Abstract][Full Text] [Related]
24. Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection. Atik B; Thanh TT; Luong VQ; Lagree S; Dean D JAMA; 2006 Sep; 296(12):1488-97. PubMed ID: 17003397 [TBL] [Abstract][Full Text] [Related]
25. Impact of health education on active trachoma in hyperendemic rural communities in Ethiopia. Edwards T; Cumberland P; Hailu G; Todd J Ophthalmology; 2006 Apr; 113(4):548-55. PubMed ID: 16581416 [TBL] [Abstract][Full Text] [Related]
28. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. Chidambaram JD; Alemayehu W; Melese M; Lakew T; Yi E; House J; Cevallos V; Zhou Z; Maxey K; Lee DC; Shapiro BL; Srinivasan M; Porco T; Whitcher JP; Gaynor BD; Lietman TM JAMA; 2006 Mar; 295(10):1142-6. PubMed ID: 16522834 [TBL] [Abstract][Full Text] [Related]
29. Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics. Ervin AM; Mkocha H; Munoz B; Dreger K; Dize L; Gaydos C; Quinn TC; West SK Ophthalmic Epidemiol; 2016 Dec; 23(6):347-353. PubMed ID: 27820670 [TBL] [Abstract][Full Text] [Related]
30. Effectiveness of expanding annual mass azithromycin distribution treatment coverage for trachoma in Niger: a cluster randomised trial. Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Gaynor BD; Keenan JD; Lietman TM; Oldenburg CE Br J Ophthalmol; 2018 May; 102(5):680-686. PubMed ID: 28893761 [TBL] [Abstract][Full Text] [Related]
31. Coverage of azithromycin mass treatment for trachoma elimination in Northwestern Ethiopia: a community based cross-sectional study. Tilahun Z; Fenta TG BMC Ophthalmol; 2018 Aug; 18(1):193. PubMed ID: 30081851 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of an Australian indigenous housing programme: community level impact on crowding, infrastructure function and hygiene. Bailie RS; McDonald EL; Stevens M; Guthridge S; Brewster DR J Epidemiol Community Health; 2011 May; 65(5):432-7. PubMed ID: 20466712 [TBL] [Abstract][Full Text] [Related]
33. Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal. Holm SO; Jha HC; Bhatta RC; Chaudhary JS; Thapa BB; Davis D; Pokhrel RP; Yinghui M; Zegans M; Schachter J; Frick KD; Tapert L; Lietman TM Bull World Health Organ; 2001; 79(3):194-200. PubMed ID: 11285662 [TBL] [Abstract][Full Text] [Related]
34. Mass drug administration for trachoma: how long is not long enough? Jimenez V; Gelderblom HC; Mann Flueckiger R; Emerson PM; Haddad D PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003610. PubMed ID: 25799168 [TBL] [Abstract][Full Text] [Related]
35. Control of trachoma in Australia: a model based evaluation of current interventions. Shattock AJ; Gambhir M; Taylor HR; Cowling CS; Kaldor JM; Wilson DP PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003474. PubMed ID: 25860143 [TBL] [Abstract][Full Text] [Related]
36. Mapping Trachoma in the Solomon Islands: Results of Three Baseline Population-Based Prevalence Surveys Conducted with the Global Trachoma Mapping Project. Sokana O; Macleod C; Jack K; Butcher R; Marks M; Willis R; Chu BK; Posala C; Solomon AW Ophthalmic Epidemiol; 2016; 23(sup1):15-21. PubMed ID: 27937043 [TBL] [Abstract][Full Text] [Related]
37. Prevalence and associated factors of active trachoma among childeren aged 1-9 years in rural communities of Gonji Kolella district, West Gojjam zone, North West Ethiopia. Nigusie A; Berhe R; Gedefaw M BMC Res Notes; 2015 Nov; 8():641. PubMed ID: 26530131 [TBL] [Abstract][Full Text] [Related]
38. Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia. Astale T; Sata E; Zerihun M; Nute AW; Stewart AEP; Gessese D; Ayenew G; Melak B; Chanyalew M; Tadesse Z; Callahan EK; Nash SD PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006270. PubMed ID: 29451881 [TBL] [Abstract][Full Text] [Related]
39. Intensive insecticide spraying for fly control after mass antibiotic treatment for trachoma in a hyperendemic setting: a randomised trial. West SK; Emerson PM; Mkocha H; McHiwa W; Munoz B; Bailey R; Mabey D Lancet; 2006 Aug; 368(9535):596-600. PubMed ID: 16905024 [TBL] [Abstract][Full Text] [Related]
40. Trachoma: 1985 update in Western Australia. Cooper RL; Coid D; Constable IJ Aust N Z J Ophthalmol; 1986 Nov; 14(4):319-23. PubMed ID: 3814419 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]